MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Andy Smith is a Certified Financial ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
Endries International, Brillion, WI, a distributor of fasteners and related production components, has announced that MSD Partners, L.P., along with Endries management, has acquired Endries from ...
Amazon has been the elephant in the wholesale distribution room ever since the eCommerce behemoth began expanding beyond selling books and music CDs in the late 1990s, and especially ever since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback